Century Therapeutics Inc. (IPSC)
NASDAQ: IPSC
· Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.58
3.17%
After-hours: Aug 15, 2025, 05:56 PM EDT
Century Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 114.9M | 6.59M | 2.69M | 2.04M | 1.37M | 2.23M | 2.49M | 4.56M | 5.86M | 5.2M | 4.68M | 2.45M | 1.06M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 3.55M | 5.34M | 7.75M | 9.92M | 9.75M | 10.74M | 9.99M | 29.02M | 27.52M | 25.79M | 25.06M | 4.81M | 2.93M | 1.88M | 948K |
Gross Profit | 114.9M | 6.59M | -867K | -3.3M | -6.38M | -7.68M | -7.26M | -6.17M | -4.13M | -23.82M | -22.84M | -23.34M | -24M | -4.81M | -2.93M | -1.88M | -948K |
Operating Income | -32.65M | -138.14M | -144.62M | -145.45M | -145.77M | -146.55M | -136.09M | -132.2M | -128.48M | -133.83M | -128.5M | -122.59M | -114.26M | -94.88M | -82.17M | -69.47M | -61.97M |
Interest Income | 12.19M | 13.01M | 13.63M | 13.81M | 13.29M | 12.68M | 9.19M | 6.73M | 4.39M | 2.02M | 1.99M | 1.1M | 459K | 234K | 234K | 214K | 363K |
Pretax Income | -20.16M | -124.78M | -130.75M | -131.64M | -132.8M | -134.79M | -126.17M | -124.77M | -123.4M | -130.84M | -127.34M | -122.63M | -114.93M | -95.78M | -83.16M | -70.22M | -62.25M |
Net Income | -21.95M | -126.57M | -129.89M | -131.39M | -133.47M | -136.67M | -128.96M | -126.99M | -124.68M | -130.93M | -127.44M | -122.7M | -114.99M | -95.82M | -83.16M | -70.22M | -62.25M |
Selling & General & Admin | 32.82M | 33.16M | 33.99M | 34.62M | 34.55M | 34.71M | 34.36M | 33.44M | 33.46M | 31.86M | 29.79M | 28.01M | 23.84M | 19.23M | 15.87M | 11.91M | 10.13M |
Research & Development | 110.4M | 107.24M | 100.17M | 95.72M | 91.23M | 92.71M | 96M | 99.11M | 100.88M | 107.17M | 103.38M | 97.03M | 91.47M | 75.65M | 66.29M | 57.56M | 47.11M |
Other Expenses | 4.33M | 4.33M | 13.14M | 13.16M | 12.97M | 12.78M | 1.7M | 3.08M | 3.26M | 13.46M | 11.39M | 10M | 10M | 28K | 28K | 28K | 28K |
Operating Expenses | 147.55M | 144.73M | 147.3M | 143.49M | 138.92M | 140.56M | 130.36M | 132.55M | 134.34M | 139.03M | 133.18M | 125.04M | 115.31M | 94.88M | 82.17M | 69.47M | 57.24M |
Interest Expense | n/a | n/a | n/a | n/a | 136K | 540K | 858K | 1.15M | 1.27M | 1.11M | 826K | 775K | 763K | 839K | 1.07M | 874K | 632K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 147.55M | 144.73M | 147.3M | 143.49M | 138.92M | 140.56M | 130.36M | 132.55M | 134.34M | 139.03M | 133.18M | 125.04M | 115.31M | 94.88M | 82.17M | 69.47M | 57.24M |
Income Tax Expense | 1.79M | 1.79M | -854K | -254K | 674K | 1.88M | 2.78M | 2.21M | 1.28M | 91K | 102K | 140K | 112K | 96K | 53K | 96K | 106K |
Shares Outstanding (Basic) | 86.02M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.39M | 57.05M | 54.47M | 54.47M | 54.4M | 54.82M |
Shares Outstanding (Diluted) | 86.1M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.69M | 57.05M | 54.47M | 54.47M | 54.4M | 54.82M |
EPS (Basic) | -0.32 | -1.66 | -1.86 | -2.04 | -2.22 | -2.3 | -2.18 | -2.16 | -2.14 | -2.27 | -2.25 | -2.2 | -2.09 | -1.76 | -1.61 | -1.44 | -1.38 |
EPS (Diluted) | -0.32 | -1.66 | -1.86 | -2.04 | -2.22 | -2.3 | -2.18 | -2.16 | -2.14 | -2.27 | -2.25 | -2.2 | -2.09 | -1.76 | -1.61 | -1.44 | -1.38 |
EBITDA | -9.24M | -114.72M | -120.46M | -122.86M | -124.94M | -124.33M | -115.47M | -112.71M | -111.89M | -121.59M | -120.65M | -117.72M | -110.83M | -90.97M | -78.73M | -66.69M | -59.62M |
EBIT | -22.54M | -128.03M | -134M | -134.89M | -135.91M | -134.31M | -125.37M | -123.67M | -122.18M | -129.74M | -126.31M | -121.65M | -113.96M | -94.81M | -82.1M | -69.36M | -61.63M |
Depreciation & Amortization | 13.3M | 13.3M | 13.54M | 12.03M | 10.97M | 9.92M | 9.75M | 10.74M | 9.99M | 8.98M | 7.49M | 5.76M | 5.02M | 4.81M | 3.44M | 2.8M | 2.15M |